Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NOVN Novan (NOVN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Novan Stock (NASDAQ:NOVN) 30 days 90 days 365 days Advanced Chart Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get Novan alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume7.19 million shsAverage Volume602,421 shsMarket Capitalization$2.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNovan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina.Read More… The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Receive NOVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter. Email Address NOVN Stock News HeadlinesNovartis AGFebruary 27, 2024 | wsj.comNovartis AG Registered SharesFebruary 16, 2024 | morningstar.comBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…November 21, 2024 | Crypto 101 Media (Ad)Novartis AG Registered Shares NOVNOctober 31, 2023 | morningstar.comNovan reaches deals to sell assets in bankruptcy caseSeptember 8, 2023 | bizjournals.comFirm Retention Summary: NovanAugust 8, 2023 | msn.comNovan (NOVN) Price Target Increased by 43.52% to 15.81August 3, 2023 | msn.comNovan Shares Hit 52-Week Low After Bankruptcy DeclarationJuly 17, 2023 | marketwatch.comSee More Headlines NOVN Stock Analysis - Frequently Asked Questions How were Novan's earnings last quarter? Novan, Inc. (NASDAQ:NOVN) announced its earnings results on Monday, May, 15th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.32) by $0.22. The company earned $3.17 million during the quarter, compared to the consensus estimate of $6.19 million. Novan had a negative net margin of 128.61% and a negative trailing twelve-month return on equity of 700.28%. When did Novan IPO? Novan (NOVN) raised $46 million in an IPO on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray acted as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers. What other stocks do shareholders of Novan own? Based on aggregate information from My MarketBeat watchlists, some other companies that Novan investors own include Meta Platforms (META), Bionano Genomics (BNGO), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), NIO (NIO), Tesla (TSLA) and Zomedica (ZOM). Company Calendar Last Earnings5/15/2023Today11/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:NOVN CUSIPN/A CIK1467154 Webwww.novan.com Phone(919) 485-8080Fax919-237-9212Employees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-31,310,000.00 Net Margins-128.61% Pretax Margin-128.39% Return on Equity-700.28% Return on Assets-39.58% Debt Debt-to-Equity RatioN/A Current Ratio0.74 Quick Ratio0.72 Sales & Book Value Annual Sales$24.71 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.19 per share Price / BookN/AMiscellaneous Outstanding Shares28,015,000Free Float27,651,000Market Cap$2.64 million OptionableNot Optionable Beta-0.06 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:NOVN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novan With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.